The FDA has accepted the application for belzutifan for advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025.

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma.

CT Attorney General William Tong, Gov. Ned Lamont, members of the state's Congressional delegation and other government officials discuss the legality of President Donald Trump's memo pausing ...

Information can be provided anonymously at 860- 570-8969 or [email protected]. Trump ties CT transportation funding to immigration compliance, birth rates. ‘A confusing mess’: Lamont.

Some CT restaurants struggle, others are booming. Experts explain why, new worries, what can help. Some CT restaurants struggle, others are booming. Experts explain why, new worries, what can help.

Editor’s note: For more coverage of the long-term care insurance industry, please click here. Key lawmakers this week said there is an urgent need to reform long-term care insurance for ...

The number has been disconnected. If you notice a donation box that you think is breaking the rules, you can report it to state investigators by emailing [email protected].

ON Semiconductor Corp. (ON) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. ON ...